CRISPR Therapeutics AG (CRSP) ownership: Top institutional holder: ARK Investment Management LLC ($538.19M). 3 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| ARK Investment Management LLC | 11313623.00 | $538.19M | 2026-03-31 |
| BlackRock, Inc. | 7680073.00 | $365.34M | 2026-03-31 |
| Orbis Allan Gray Ltd | 6106011.00 | $290.46M | 2026-03-31 |
| Capital World Investors | 4725037.00 | $224.77M | 2026-03-31 |
| STATE STREET CORP | 3982500.00 | $189.45M | 2026-03-31 |
| GSK plc | 3220627.00 | $153.21M | 2026-03-31 |
| T. Rowe Price Investment Management, Inc. | 2952595.00 | $140.46M | 2026-03-31 |
| VANGUARD GROUP INC | 2268394.00 | $118.95M | 2025-12-31 |
Back to CRSP overview · CRSP earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.